Generic Name and Formulations:
Alvimopan 12mg; hard-gelatin caps.
Cubist Pharmaceuticals, Inc.
Indications for ENTEREG:
To accelerate the time to upper and lower gastrointestinal recovery following surgeries that include partial bowel resection surgery with primary anastomosis.
Give 12mg 30mins to 5hrs before surgery, then 12mg twice daily starting on 1st post-op day until hospital discharge for up to 7 days; max 15 doses.
Opioid antagonist (peripheral).
Opioid use, at therapeutic doses, for >7 consecutive days prior.
For short-term hospital use only. Potential risk of MI with long-term use. Severe hepatic impairment, ESRD, complete GI obstruction, pancreatic or gastric anastomosis: not recommended. Mild-to-severe renal impairment or mild-to-moderate hepatic impairment: monitor closely; discontinue if adverse reactions occur. Recent (within week prior to surgery) use of >3 doses of opioids; monitor for GI events. Japanese patients (monitor). Pregnancy (Cat.B). Nursing mothers.
Available only to hospitals that enroll in Entereg Access Support and Education Program (EASE). For more information, and to enroll, call (877) 282-4786.
- Necessary Procedure Leads to Assault and Battery Charges
- Two Older Antibiotics Effective Against Community-Acquired MRSA, Says New Research
- Over 50,000 Bottles of Cholesterol Drug Recalled
- Certain Antibiotics May Up Diabetes Risk
- FDA: Life-Threatening Interaction Possible Between Antivirals, Amiodarone
- New Duodenoscope Cleaning Instructions Issued for Reprocessing Procedure
- Educating Clinicians on Safe Opioid Prescribing Part of New HHS Program
- Targeted Immunotherapy for Alzheimer's Could Reverse Memory Problems
- NIH: HIV Can Evolve, Replicate in Brain During Early Infection
- Comparing Roseroot Herb, Sertraline for MDD Treatment